Opportunity for severe and critical COVID-19 pneumonia treatment with corticosteroids: a retrospective cohort study.

ABSTRACT:

Background

The coronavirus disease 2019 (COVID-19) pandemic has been the most significant infectious disease outbreak worldwide in the past 3 years, with the potential to progress to severe pneumonia and trigger systemic inflammatory response, posing a threat to human health and life. This study aims to explore the use of corticosteroids for COVID-19 and provide recommendations on the timing and dosage of the treatment.

Methods

We conducted a retrospective cohort study, enrolling 100 with COVID-19 pneumonia between December 2022 and January 2023. The diagnosis of severe and critical COVID-19 pneumonia patients was according to China's Ninth Edition of the Diagnosis and Treatment Plan for COVID-19 Pneumonia. T test and univariate proportional hazard analysis were employed to

SUBMITTER: Chen F 

PROVIDER: S-EPMC11494557 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature